The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase II study of oral metronomic combination therapy in relapsed epithelial ovarian cancer.
Sudeep Gupta
No relevant relationships to disclose
Gautam Goyal
No relevant relationships to disclose
Jaya Ghosh
No relevant relationships to disclose
Bharatsinha Baburao Bhosale
No relevant relationships to disclose
Jyoti Bajpai
No relevant relationships to disclose
Amita Maheshwari
No relevant relationships to disclose
Rajendra Kerkar
No relevant relationships to disclose
Kedar Deodhar
No relevant relationships to disclose
Bharat Rekhi
No relevant relationships to disclose
Santosh Menon
No relevant relationships to disclose
Shripad Banavali
No relevant relationships to disclose